Breaking News

SGS introduces in vitro toxicology testing at its Canadian lab

The investment includes an expansion of existing cell/tissue culture capabilities, flow cytometry and mass spectrometry ...

Quotient Sciences expands early-phase formulation facility

The drug development services organisation has announced a significant expansion to its operations in the US

Almac passes HSA inspection at its Singapore facility

The facility serves as the companies' Asia Pacific headquarters and aims to optimise the clinical supply chain for ...

The fine art of plant management and outsourced manufacturing

Dr Kevin Robinson caught up with John Andrews, Director of Operations in Charles City (Iowa, US), to get the Cambrex ...

Almac Group expands existing North Carolina facility

The CDMO has invested in its clinical services and diagnostic service capabilities

Noramco announces provisional patent application of proprietary cannabidiol (CBD)

Filing with the US Patent and Trademark Office covers pure cannabidiol compositions

Serialisation and data connectivity: Part II

The new wrinkle in your supply chain, click here to read part I

To comply with EU FMD Fareva selects TraceLink

The API CDMO has selected the track and trace network provider, so that it can successfully connect with its ...

PCI highlights its growth at CPhI

Three acquisitions in 12 months bolsters PCI’s global position for speed-to-market in support of its clients’ drug ...

The rise of independent excipients

The pressure to innovate faster than their competitors has drug formulators exploring new ways to optimise m ...

ATP detection: The balance between precision and speed

Adenosine triphosphate (ATP) is an indicator molecule for the presence of biological residues used in food production. ...

How does the EU shape up to its transpondian neighbours?

While at FutureLink 2018, which took place in June, Angharad Baldwin caught up with Jean-Marie Aulnette, VP of EMEA at ...

Catalent invests $7.3 million in Italian facility

The oral and topical softgel technology specialist is aiming to solve complex bioavailability and formulation challenges

PCI completes acquisition of Sherpa Clinical Packaging

The acquisition enhances PCI’s portfolio of molecule-to-market capabilities, adding sterile and non-sterile drug ...